Mao, Binchen

De novo design of a fluorescence-activating β-barrel

Dou, J., Vorobieva, A. A., Sheffler, W., Doyle, L. A., Park, H., Bick, M. J., Mao, B., Foight, G. W., Lee, M. Y., Gagnon, L. A., et al. (2018) · Nature

Protein Structure and DynamicsBiochemical and Structural Characterization

Cited by 351

Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment

Jin, Y., An, X., Mao, B., Sun, R., Kumari, R., Chen, X., Shan, Y., Zang, M., Xu, L., Muntel, J., et al. (2022) · Scientific Reports

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 73

The design, analysis and application of mouse clinical trials in oncology drug development

Guo, S., Jiang, X., Mao, B., & Li, Q.-X. (2019) · BMC Cancer

Statistical Methods in Clinical TrialsAnimal testing and alternatives

Cited by 68

Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models

Mao, B., & Guo, S. (2023) · Cancer Research Communications

Statistical Methods in Clinical TrialsComputational Drug Discovery Methods

Cited by 27

Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

Shi, Z., Mao, B., Chen, X., Hao, P., & Guo, S. (2023) · Cancer Research Communications

Advanced Proteomics Techniques and ApplicationsBioinformatics and Genomic Networks

Cited by 7

Data from Mouse Stromal Cells Confound Proteomic Characterization and Quantification of Xenograft Models

Shi, Z., Mao, B., Chen, X., Hao, P., & Guo, S. (2023)

Advanced Proteomics Techniques and ApplicationsBioinformatics and Genomic Networks

Cited by 0